4
Changes in Ownership
KYNTRA BIO, INC. Filed Acc 0001209191-20-059427
SVP, Clinical Dev, Drug Safety acquired 7,082 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Kouchakji Elias · SVP, Clinical Dev, Drug Safety
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-11-17 | Exercise or conversion : show line 1 in the form | +7,082 | $14.58 | $103,220 | 134,495 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2020-11-17 | Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) | −7,082 | $14.58 | 2024-03-19 | 7,082 | 0 | D |
Loading xslF345X03/doc4.xml…